CIMA LABS Awarded U.S. Patent for Microemulsion Oral Drug Delivery Technology.

Business Editors & Health/Medical Writers

EDEN PRAIRIE Eden Prairie

A city of eastern Minnesota, a residential suburb of Minneapolis. Population: 57,300. , Minn.--(BUSINESS WIRE)--Sept. 19, 2001

CIMA LABS, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec. . (Nasdaq:CIMA) today announced the issuance of a patent (No. 6,280,770), "Microemulsions as Solid Dosage Forms A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug. for Oral Administration," from the U.S. Patent and Trademark office for a new drug delivery technology.

The Company, which believes this technology can be used to improve the bioavailability bioavailability /bio·avail·a·bil·i·ty/ (bi?o-ah-val?ah-bil´i-te) the degree to which a drug or other substance becomes available to the target tissue after administration.

bi·o·a·vail·a·bil·i·ty
n. of a wide range of drugs, is evaluating applications for this patented drug delivery system.

About CIMA

CIMA develops and manufactures prescription and over-the-counter products for pharmaceutical companies based upon its proprietary, fast-dissolve drug delivery technologies, OraSolv(R) and DuraSolv(TM). CIMA formulates a pharmaceutical company's active drug ingredient into a new, orally disintegrating dosage form that dissolves quickly in the mouth without chewing or the need for water. Taste masking mask·ing
n.
1. The concealment or the screening of one sensory process or sensation by another.

2. An opaque covering used to camouflage the metal parts of a prosthesis. agents may be used with the Company's fast-dissolve technologies to prevent or minimize the unpleasant taste associated with many active drug ingredients. CIMA currently manufactures five pharmaceutical brands utilizing its OraSolv and DuraSolv technologies: three prescription and two over-the-counter.

COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Geographic Code:	1USA
Date:	Sep 19, 2001
Words:	174
Previous Article:	Purchasing Magazine Says Supply Deliveries Continue to be Disrupted.
Next Article:	County Bank Supports Relief Efforts.
Topics:	Chemical industry Pesticides industry

Related Articles
CIMA LABS Issued First Patent for OraVescent Drug Delivery Technology; Technology Intended to Improve Absorption Rates of Active Drug Ingredients...
CIMA LABS' DuraSolv Fast-Dissolve Oral Drug Delivery System Awarded Second U.S. Patent.
CIMA LABS' PakSolv Packaging Technology Awarded Second U.S. Patent.
ORGANON GETS FIRST EUROPEAN MARKETING APPROVAL FOR REMERON.
CIMA LABS Issued Second Patent for OraVescent Oral Drug Delivery Technology.
CIMA Granted U.S. Patents for Fast-Dissolve, Sustained Release Potassium Chloride Product As Adjunct Therapy for Hypertension.
CIMA LABS Issued Third Patent for OraVescent Oral Drug Delivery Technology.
CIMA LABS Issued Fourth Patent for OraVescent(R)Oral Drug Delivery Technology.
CIMA LABS Files Patent Infringement Complaint Against KV Pharmaceutical Company and Its Wholly-Owned Subsidiary ETHEX Corporation.